Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Other financing activities (2016 - 2025)

Myriad Genetics has reported Other financing activities over the past 15 years, most recently at -$8.6 million for Q4 2025.

  • Quarterly Other financing activities fell 2050.0% to -$8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.3 million through Dec 2025, down 2866.67% year-over-year, with the annual reading at -$200000.0 for FY2025, 50.0% up from the prior year.
  • Other financing activities was -$8.6 million for Q4 2025 at Myriad Genetics, down from -$400000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $1.2 million in Q1 2021 and troughed at -$8.6 million in Q4 2025.
  • The 4-year median for Other financing activities is $150000.0 (2022), against an average of -$1.8 million.
  • The largest YoY upside for Other financing activities was 2050.0% in 2025 against a maximum downside of 2050.0% in 2025.
  • A 4-year view of Other financing activities shows it stood at $1.2 million in 2021, then tumbled by 41.67% to $700000.0 in 2022, then tumbled by 157.14% to -$400000.0 in 2024, then tumbled by 2050.0% to -$8.6 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Other financing activities are -$8.6 million (Q4 2025), -$400000.0 (Q4 2024), and $700000.0 (Q3 2022).